Hematology, Transfusion and Cell Therapy

Advanced Search

Share

English Português

April - June 2019

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy

ISSN: 2531-1379

Hematology, Transfusion and Cell Therapy is a quarterly scientific publication of the Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular (ABHH), Associazione Italo-Brasiliana di Ematologia (AIBE), Eurasian Hematology Oncology Group (EHOG), and Sociedade Brasileira de Oncologia Pediátrica (SOBOPE).

Hematology, Transfusion and Cell Therapy publishes original articles, review articles and case reports covering various areas in the field of hematology and hemotherapy. The journal was previously published, until 2016, as Revista Brasileira de Hematologia e Hemoterapia.

ISSN print: 2531-1379
ISSN online: 2531-1387

Published by Elsevier Editora Ltda, Rio de Janeiro, Brazil.

See more

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Congresso Brasileiro de Hematologia, Hemoterapia e Terapia Celular. HEMO 2024. List of conference abstracts.

Indexed in:

Scopus, Medline, Directory of Open Access Journals (DOAJ), PubMed Central (PMC), Emerging Sources Citation Index (ESCI), SCImago Journal Rank (SJR), SNIP

See more

Follow us:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2022

See more

Impact factor 2023

1.8

Citescore

CiteScore measures average citations received per document published.

See more

Citescore 2023

2.4

CiteScore Percentile

CiteScore Percentile indicates the relative standing of a serial title in its subject field.

See more

CiteScore Percentile 2020

31 %

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

See more

SJR 2023

0.38

View more metrics

Open Access Option

Journal Information

Previous Issue | Next Issue

Issue

portada-S2531137919X00048

Vol. 41. Issue 2.

Pages 103-194 (April - June 2019)

Scientific comments

Scientific comment on: “Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon”. Who likes to take medicine forever?

Israel Bendit

Hematol Transfus Cell Ther. 2019;41:103

Open access

Share

Does gender influence reference values of platelet indices?

Magnun Nueldo Nunes dos Santos

Hematol Transfus Cell Ther. 2019;41:104-5

Open access

Share

Original articles

Analysis of imatinib adherence in chronic myeloid leukemia: a retrospective study in a referral hospital in the Brazilian Amazon

Alan Rodrigues Andrade, Daniel da Silva Leitão, Igor Penha Paz, Talitta Ribeiro Evangelista, Vanessa Joia de Mello, Moisés Hamoy

Hematol Transfus Cell Ther. 2019;41:106-13

Open access

Share

Does BCR-ABL transcript type influence the prognosis of patients in chronic myelogenous leukemia chronic phase?

T.P. de Almeida Filho, P.A. Maia Filho, Maritza Cavalcante Barbosa, Luana Letícia Alves Dutra, Marilena Facundo de Castro, Fernando Barroso Duarte, Acy Telles de Souza Quixadá, Romélia Pinheiro Gonçalves Lemes

Hematol Transfus Cell Ther. 2019;41:114-8

Open access

Share

Plasmic score applicability for the diagnosis of thrombotic microangiopathy associated with ADAMTS13-acquired deficiency in a developing country

Deivide Sousa Oliveira, Tadeu G. Lima, Fernanda L. Neri Benevides, Suzanna A. Tavares Barbosa, Maria A. Oliveira, Natália P. Boris, Herivaldo F. Silva

Hematol Transfus Cell Ther. 2019;41:119-24

Open access

Share

Management of chronic myeloid leukemia during pregnancy: a retrospective analysis at a single center

Ariella Cássia de Moura, Márcia Torresan Delamain, Gislaine Borba Oliveira Duarte, Irene Lorand-Metze, Cármino Antônio de Souza, Kátia Borgia Barbosa Pagnano

Hematol Transfus Cell Ther. 2019;41:125-8

Open access

Share

A correlation between platelet indices and preeclampsia

Nitesh Thalor, Kanika Singh, Mukta Pujani, Varsha Chauhan, Charu Agarwal, Rashmi Ahuja

Hematol Transfus Cell Ther. 2019;41:129-33

Open access

Share

Outcome of hairy cell leukemia patients treated with cladribine – a 10-year single-center experience in Pakistan

Mohammad Faizan Zahid, Mohammad Qasim Mehdi, Natasha Ali

Hematol Transfus Cell Ther. 2019;41:134-8

Open access

Share

Characterization of thalassemia major and diabetes mellitus patients at a reference center in Brazil

Gabriela Marsola Olivatto, Carla Regina de Souza Teixeira, Marcela Ganzella Sisdelli, Maria Lúcia Zanetti, Renata Cristina de Campos Pereira Silveira, Claudio Vinicius Gonçalves

Hematol Transfus Cell Ther. 2019;41:139-44

Open access

Share

Development and validation of an instrument to assess Brazilian healthcare professional providers’ knowledge on sickle cell disease

Katy Karoline Santos Diniz, Adriana Silvina Pagano, Ana Paula Pinheiro Chagas Fernandes, Ilka Afonso Reis, Leonardo Gonçalves Pinheiro Júnior, Heloísa de Carvalho Torres

Hematol Transfus Cell Ther. 2019;41:145-52

Open access

Share

Sex-divided reference intervals for mean platelet volume, platelet large cell ratio and plateletcrit using the Sysmex XN-10 automated haematology analyzer in a UK population

Usman Ali, Roz Gibbs, Gavin Knight, Dimitris Tsitsikas

Hematol Transfus Cell Ther. 2019;41:153-7

Open access

Share

Echocardiografic abnormalities in patients with sickle cell/β-thalassemia do not depend on the β-thalassemia phenotype

Bruno Deltreggia Benites, Ianara Silva Cisneiros, Stephany Oliveira Bastos, Ana Paula Beppler Lazaro Lino, Fernando Ferreira Costa, Simone Cristina Olenscki Gilli, Sara Teresinha Olalla Saad

Hematol Transfus Cell Ther. 2019;41:158-63

Open access

Share

Special article

Blood donation deferral policies among men who have sex with men in Brazil

Miriane Lucindo Zucoloto, Thelma T. Gonçalez, Willi McFarland, Brian Custer, Guilherme Galdino, Edson Z. Martinez

Hematol Transfus Cell Ther. 2019;41:164-8

Open access

Share

Review article

Targeted therapy with a selective BCL-2 inhibitor in older patients with acute myeloid leukemia

Elisabete do Vale Campos, Ricardo Pinto

Hematol Transfus Cell Ther. 2019;41:169-77

Open access

Share

Case reports

A rare case of primary conjunctival Follicular Lymphoma grade 3B

Marcelo Bellesso, Leonardo P. Nicioli, Yara Menezes, Rodrigo Santucci

Hematol Transfus Cell Ther. 2019;41:178-80

Open access

Share

Additional information offered by single nucleotide polymorphism array advantages in two myelodysplastic syndromes with excess blasts cases and future perspectives

Thiago Rodrigo de Noronha, Miguel Mitne-Neto, Maria de Lourdes Chauffaille

Hematol Transfus Cell Ther. 2019;41:181-4

Open access

Share

Images in clinical hematology

Malaria, the role of the blood smear – a case report

Marco P. Barros Pinto

Hematol Transfus Cell Ther. 2019;41:185-6

Open access

Share

Letters to the editor

Reference intervals of the platelet indexes in a healthy population in Santa Maria, Rio Grande do Sul, Brazil

Karla Nunes Pereira, José Antonio Mainardi de Carvalho, Clóvis Paniz

Hematol Transfus Cell Ther. 2019;41:187-9

Open access

Share

Prevalence of D variants in the Indian donor population

Rajeswari Subramaniyan

Hematol Transfus Cell Ther. 2019;41:190-3

Open access

Share

Publish in

Hematology, Transfusion and Cell Therapy

Hematology, Transfusion and Cell Therapy is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Idiomas

Hematology, Transfusion and Cell Therapy

Home
All contents
Publish your article
About the journal
- Aims and scope
- Editorial Board
Metrics